Decatur, Georgia
CNS clinical trials in Decatur, GA
33 CNS studies are recruiting participants at sites in Decatur as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Decatur at a glance
- 33 studies are recruiting at a site in Decatur.
- By phase: Phase 1 (3), Phase 2 (11), Phase 2/3 (1), Phase 3 (15), Phase 4 (2), No phase (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (31), government (1), university, hospital or other (1).
- By research area: Depression (12), Schizophrenia (11), Migraine (3), Parkinson's Disease (3), ADHD (2), Bipolar Disorder (2).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Decatur
Basic details from each study's public record (the 30 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Cenexel iResearch Atlanta
- Registry record
- NCT07226661 · updated
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Seaport Therapeutics
- Study site
- Seaport Investigator Site
- Registry record
- NCT07065240 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- CenExel - iResearch Atlanta
- Registry record
- NCT07592689 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Emory Decatur Hospital
- Registry record
- NCT06748222 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT07412756 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- CenExeli Research LLC
- Registry record
- NCT05850689 · updated
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07610473 · updated
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07300969 · updated
Brexanolone Lifting Outcomes Of Moms
- Phase 3
- Ages 15 to 45
- Female participants
- Sponsor
- Lipocine Inc.
- Study site
- Lipocine Investigational Site
- Registry record
- NCT07822321 · updated
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- CenExcel iResearch LLC /ID# 228695
- Registry record
- NCT04777357 · updated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Cenexel Decatur GA
- Registry record
- NCT07494305 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Decatur, GA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Decatur
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT07565428 · updated
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT05648591 · updated
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07114874 · updated
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Phase 1
- Ages 18 to 55
- All sexes
- Sponsor
- Leal Therapeutics, Inc
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT07734493 · updated
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Phase 1
- Ages 18 to 55
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT07061288 · updated
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigator Site
- Registry record
- NCT05303064 · updated
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Phase 1
- Ages 10 to 17
- All sexes
- Sponsor
- BioXcel Therapeutics Inc
- Study site
- Bioxcel Clinical Research Site
- Registry record
- NCT05025605 · updated
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- CenExel iResearch
- Registry record
- NCT07467993 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Decatur, GA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Decatur
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT06951711 · updated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT06929273 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Decatur, GA on ClinicalTrials.gov.
ADHD studies recruiting in Decatur
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07755410 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- CenExcel iResearch, LLC
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Decatur, GA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Decatur
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Vima Therapeutics
- Study site
- Vima Site #045
- Registry record
- NCT07804615 · updated
A Study of Buntanetap in Participants With PD
- Phase 2/3
- Ages 40 to 85
- All sexes
- Sponsor
- Annovis Bio Inc.
- Study site
- iResearch Atlanta
- Registry record
- NCT07284784 · updated
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- No phase
- Ages 40 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Atlanta VA Medical and Rehab Center, Decatur, GA
- Registry record
- NCT06088355 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Decatur, GA on ClinicalTrials.gov.
Migraine studies recruiting in Decatur
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Accel Research Site-Decatur-Alcanza
- Registry record
- NCT07616128 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- CenExel iResearch, LLC
- Registry record
- NCT04743141 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Decatur, GA on ClinicalTrials.gov.
Ask about studies near Decatur
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Georgia
All Georgia locations
139 studies recruiting across 23 cities.
Atlanta
90 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections